Seeking an optimal eradication therapy for Helicobacter pylori infection.
作者： Soichiro Miura , Ryota Hokari
DOI: 10.1111/J.1440-1746.2011.06953.X
关键词:
摘要:
sci-hub.se 参考文章(29)
Mutsuhiro Ikuma, Mihoko Yamade, Takahisa Furuta, Mitsushige Sugimoto, Masafumi Nishino, Naohito Shirai, Chise Kodaira, Takahiro Uotani, The dual therapy with 4 times daily dosing of rabeprazole and amoxicillin as the 3rd rescue regimen for eradication of H. pylori. Hepato-gastroenterology. ,vol. 57, pp. 1314- 1319 ,(2010)
Taraq A Attumi, David Y Graham, Increasing the duration of dual amoxicillin plus omeprazole Helicobacter pylori eradication to 6 weeks: a pilot study. Journal of Gastroenterology and Hepatology. ,vol. 27, pp. 59- 61 ,(2012) , 10.1111/J.1440-1746.2011.06876.X
Seung Young Kim, Sung Woo Jung, Jeong Han Kim, Ja Seol Koo, Hyung Joon Yim, Jong Jae Park, Hoon Jai Chun, Sang Woo Lee, Jai Hyun Choi, Effectiveness of three times daily lansoprazole/amoxicillin dual therapy for Helicobacter pylori infection in Korea British Journal of Clinical Pharmacology. ,vol. 73, pp. 140- 143 ,(2012) , 10.1111/J.1365-2125.2011.04048.X
Takahisa Furuta, Yukiko Sagehashi, Naohito Shirai, Mitsushige Sugimoto, Akiko Nakamura, Makoto Kodaira, Kazumi Kenmotsu, Makoto Nagano, Tohru Egashira, Koji Ueda, Masao Yoneyama, Kyoichi Ohashi, Takashi Ishizaki, Akira Hishida, Influence of CYP2C19 Polymorphism and Helicobacter pylori Genotype Determined From Gastric Tissue Samples on Response to Triple Therapy for H pylori Infection Clinical Gastroenterology and Hepatology. ,vol. 3, pp. 564- 573 ,(2005) , 10.1016/S1542-3565(04)00779-7
J. P. Gisbert, X. Calvet, Review article: non-bismuth quadruple (concomitant) therapy for eradication of Helicobater pylori Alimentary Pharmacology & Therapeutics. ,vol. 34, pp. 604- 617 ,(2011) , 10.1111/J.1365-2036.2011.04770.X
Ping-I. Hsu, Deng-Chyang Wu, Jeng-Yih Wu, David Y. Graham, Modified Sequential Helicobacter pylori Therapy: Proton Pump Inhibitor and Amoxicillin for 14 Days with Clarithromycin and Metronidazole added as a Quadruple (Hybrid) Therapy for the Final 7 Days Helicobacter. ,vol. 16, pp. 139- 145 ,(2011) , 10.1111/J.1523-5378.2011.00828.X
E. Gené, X. Calvet, R. Azagra, J. P. Gisbert, Triple vs. quadruple therapy for treating Helicobacter pylori infection: an updated meta-analysis Alimentary Pharmacology & Therapeutics. ,vol. 17, pp. 1137- 1143 ,(2003) , 10.1046/J.1365-2036.2003.01566.X
Richard J. Saad, Philip Schoenfeld, Hyungjin Myra Kim, William D. Chey, Levofloxacin-Based Triple Therapy versus Bismuth-Based Quadruple Therapy for Persistent Helicobacter pylori Infection: A Meta-Analysis The American Journal of Gastroenterology. ,vol. 101, pp. 488- 496 ,(2006) , 10.1111/J.1572-0241.2006.00637.X
Hirohisa Tanimura, Sunao Kawano, Mitsuhiko Kubo, Takashi Abe, Moritaka Goto, Jun Tanabe, Akira Asai, Terukazu Ito, Does Helicobacter pylori eradication depend on the period of amoxicillin treatment? A retrospective study Journal of Gastroenterology. ,vol. 33, pp. 23- 26 ,(1998) , 10.1007/PL00009962
Amanda J Leach, Peter S Morris, John D Mathews, Chronic Otitis Media Intervention Trial–One (COMIT1) group amanda@ menzies. edu. au, None, Compared to placebo, long-term antibiotics resolve otitis media with effusion (OME) and prevent acute otitis media with perforation (AOMwiP) in a high-risk population: A randomized controlled trial BMC Pediatrics. ,vol. 8, pp. 23- 31 ,(2008) , 10.1186/1471-2431-8-23